| Primary |
| Product Used For Unknown Indication |
11.1% |
| Laceration |
10.0% |
| Scratch |
6.8% |
| Skin Lesion |
6.3% |
| Thermal Burn |
6.3% |
| Hypertension |
5.8% |
| Drug Use For Unknown Indication |
5.3% |
| Sleep Disorder |
5.3% |
| Wound |
5.3% |
| Skin Laceration |
4.7% |
| Ulcer |
4.7% |
| Scar |
4.2% |
| Tanning |
3.7% |
| Blister |
3.2% |
| Diabetes Mellitus |
3.2% |
| Gastrooesophageal Reflux Disease |
3.2% |
| Muscle Spasms |
3.2% |
| Seasonal Allergy |
3.2% |
| Infection Prophylaxis |
2.6% |
| Anticoagulant Therapy |
2.1% |
|
| Rash |
18.1% |
| Drug Hypersensitivity |
17.4% |
| Off Label Use |
13.9% |
| No Adverse Event |
4.9% |
| Urticaria |
4.9% |
| Wound Secretion |
4.9% |
| Swelling |
3.5% |
| Anaphylactic Shock |
2.8% |
| Application Site Scar |
2.8% |
| Hypersensitivity |
2.8% |
| Product Quality Issue |
2.8% |
| Pruritus |
2.8% |
| Skin Exfoliation |
2.8% |
| Swelling Face |
2.8% |
| Thermal Burn |
2.8% |
| Application Site Swelling |
2.1% |
| Blister |
2.1% |
| Dermatitis Contact |
2.1% |
| Lip Swelling |
2.1% |
| Ocular Hyperaemia |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
13.0% |
| Scar |
12.3% |
| Skin Lesion |
12.3% |
| Tanning |
12.3% |
| Ulcer |
12.3% |
| Gastrooesophageal Reflux Disease |
5.6% |
| Chronic Obstructive Pulmonary Disease |
5.3% |
| Ill-defined Disorder |
4.2% |
| Laceration |
2.8% |
| Drug Use For Unknown Indication |
2.5% |
| Seasonal Allergy |
2.5% |
| Blister |
2.1% |
| Scratch |
2.1% |
| Atrial Fibrillation |
1.8% |
| Ear Infection |
1.8% |
| Contraception |
1.4% |
| Convulsion |
1.4% |
| Melanocytic Naevus |
1.4% |
| Pain |
1.4% |
| Prophylaxis |
1.4% |
|
| Drug Hypersensitivity |
24.2% |
| Product Quality Issue |
7.4% |
| Hypersensitivity |
5.3% |
| Nervousness |
5.3% |
| Photosensitivity Reaction |
5.3% |
| Skin Exfoliation |
5.3% |
| Stress |
5.3% |
| Sunburn |
5.3% |
| Urinary Tract Infection |
5.3% |
| Weight Decreased |
5.3% |
| Inflammation |
4.2% |
| Infection |
3.2% |
| Rash |
3.2% |
| Skin Discolouration |
3.2% |
| Application Site Scar |
2.1% |
| Drug Ineffective |
2.1% |
| Lip Exfoliation |
2.1% |
| Rash Papular |
2.1% |
| Staphylococcal Infection |
2.1% |
| Swelling Face |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.8% |
| Drug Use For Unknown Indication |
14.1% |
| Pain |
7.8% |
| Rheumatoid Arthritis |
5.2% |
| Non-small Cell Lung Cancer |
5.0% |
| Surgery |
3.9% |
| Multiple Sclerosis |
3.3% |
| Insomnia |
3.1% |
| Hepatitis C |
2.9% |
| Infection Prophylaxis |
2.7% |
| Hiv Infection |
2.5% |
| Multiple Myeloma |
2.5% |
| Crohn's Disease |
2.3% |
| Diarrhoea |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Hypertension |
2.3% |
| Metastases To Prostate |
2.3% |
| Colitis Ulcerative |
1.9% |
| Anxiety |
1.7% |
| Asthma |
1.7% |
|
| Urinary Tract Infection |
13.8% |
| Pneumonia |
7.5% |
| Vasculitis |
7.5% |
| Fall |
6.3% |
| Lung Adenocarcinoma |
6.3% |
| Tremor |
6.3% |
| Oedema Peripheral |
5.0% |
| Pharmaceutical Product Complaint |
5.0% |
| Toxic Encephalopathy |
5.0% |
| Weight Decreased |
5.0% |
| Arthralgia |
3.8% |
| Swelling |
3.8% |
| Tricuspid Valve Incompetence |
3.8% |
| Urinary Retention |
3.8% |
| Venous Insufficiency |
3.8% |
| Vision Blurred |
3.8% |
| Bone Lesion |
2.5% |
| Drug Dependence |
2.5% |
| Drug Ineffective |
2.5% |
| Fungaemia |
2.5% |
|
